Hematology/Oncology

Top Story

VIDEO: Intralesional therapies may improve personalized care for patients with melanoma

March 28, 2017

NEW YORK — Merrick I. Ross, MD, professor in the department of surgery at The University of Texas MD Anderson Cancer Center, discussed the impact of intralesional therapies on preventing recurrent melanoma at HemOnc Today Melanoma and Cutaneous Malignancies.

Meeting News

Calabrese: Checkpoint inhibitors may produce rheumatic side effects

March 28, 2017
NEW YORK — Checkpoint inhibitors — which are effective as cancer therapy — may yield side effects that are rheumatic, according to Leonard H
In the Journals

Paid malpractice claims among US physicians declined significantly

March 28, 2017
Between 1992 and 2014, there was a significant decline in paid malpractice claims, possibly due to several factors, including the passage of traditional tort reforms…
In the Journals Plus

Chemotherapy combination superior to monotherapy in resected pancreatic cancer

March 28, 2017
The combination of gemcitabine plus capecitabine demonstrated superior survival outcomes compared with gemcitabine alone in patients with pancreatic cancer who underwent…
FDA News

FDA grants Lynparza priority review for maintenance treatment of ovarian cancer

March 28, 2017
The FDA granted olaparib priority review for the maintenance treatment of patients with platinum-sensitive, relapsed ovarian cancer. The new drug application for…
More News Headlines »
CME

Immuno-Oncology Forum: Focus on Non-Small Cell Lung Cancer

This activity is supported by educational grants from Bristol-Myers Squibb; Genentech, Inc.; and Merck & Co., Inc.

Lung cancer accounts for 27% of all cancer deaths in the United States, making it the leading cause of cancer…
More »
Video
Meeting News

VIDEO: Sancy Leachman, MD, PhD, FAAD, discusses 'War on Melanoma' registry

March 22, 2017
More »
Featured
HEMONC TODAY Melanoma and Cutaneous Malignancies

HEMONC TODAY Melanoma and Cutaneous Malignancies

CME

Diagnostic and Therapeutic Challenges in Von Willebrand Disease

This activity is supported by an educational grant from Shire.

With the significant variability in the subtypes and clinical manifestations of von Willebrand disease (VWD), diagnosis…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement